Healthcare

  • APNewsBreak: Arkansas execution plan may use UK firm's drug Associated Press - Sat, Sep 19, 2015 3:39 AM AEST

    A British pharmaceutical company that told Arkansas not to use its products during executions is trying to determine if the state plans to use them anyway, but prison officials are dismissing inquiries ...

  • Novel plan to curb drug costs seeks candidates' attention Associated Press - Sat, Sep 19, 2015 3:35 AM AEST
    Novel plan to curb drug costs seeks candidates' attention

    Consumer-friendly ratings of the benefits of new drugs. Limits on what patients pay. Requiring drug companies to disclose how much they actually spend on research. With the public concerned about the high ...

  • Universal Health Services buying Foundations for $350M Associated Press - Sat, Sep 19, 2015 1:54 AM AEST

    Universal Health Services, one of the largest hospital operators in the U.S., said Friday it will buy addiction treatment facility company Foundations Recovery Network for $350 million. Foundations provides ...

  • Hospital examines deaths of 2 patients with mold infections Associated Press - Fri, Sep 18, 2015 9:12 AM AEST

    A hospital in Pittsburgh is investigating whether the deaths of two patients are linked to infections from mold they may have contracted while in an intensive care unit. UPMC Presbyterian said this week ...

  • Study: Type 2 diabetes pill Jardiance cuts risk of death Associated Press - Fri, Sep 18, 2015 6:29 AM AEST
    Study: Type 2 diabetes pill Jardiance cuts risk of death

    Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications, a study shows, making the Type 2 diabetes medication the first shown to lengthen diabetics' lives. The ...

  • FDA flags infection issue with new type of medical scope Associated Press - Fri, Sep 18, 2015 2:24 AM AEST

    Federal health regulators are drawing attention to the risk of infections with medical scopes used to examine breathing passages, following similar problems with scopes used in the stomach and intestines. ...

  • Rite Aid beats Street 2Q forecasts Associated Press - Thu, Sep 17, 2015 11:58 PM AEST

    Shares of Rite Aid tumbled Thursday after the nation's third-largest drugstore chain lowered its annual profit forecast again and reported fiscal second-quarter earnings that tumbled 83 percent partly ...

  • Perrigo urges shareholders to reject Mylan takeover offer Associated Press - Thu, Sep 17, 2015 10:03 PM AEST

    Perrigo urged shareholders to reject Mylan's $27 billion hostile takeover offer, saying it undervalues the company. On Tuesday, Mylan took its offer directly to Perrigo's shareholders after it had been ...

  • APNewsBreak: Man claims bias over use of HIV-blocking drug Associated Press - Thu, Sep 17, 2015 7:51 AM AEST
    APNewsBreak: Man claims bias over use of HIV-blocking drug

    As a gay man, the Boston attorney thought he was doing the responsible thing when he asked his doctor to prescribe Truvada, a drug hailed as a way to halt the spread of AIDS. But when he tried to get long-term ...

  • Merck: Long-acting diabetes pill works same as its Januvia Associated Press - Thu, Sep 17, 2015 4:41 AM AEST

    Drugmaker Merck & Co. says its experimental Type 2 diabetes drug performed about as well as its older daily pill, Januvia, in a late-stage patient test. The new drug, once-weekly omarigliptin, reduced ...

  • Dentsply buying dental products rival Sirona for $5.51B Associated Press - Wed, Sep 16, 2015 9:39 AM AEST

    Dentsply International is buying competitor Sirona Dental Systems for about $5.51 billion in a deal the companies say will create the biggest maker of professional dental products and materials in the ...

  • FDA halts sales of 4 R.J. Reynolds cigarette brands Associated Press - Wed, Sep 16, 2015 8:57 AM AEST
    FDA halts sales of 4 R.J. Reynolds cigarette brands

    The Food and Drug Administration on Tuesday banned sales of four cigarette brands from R.J. Reynolds because they did not meet the agency's safety review requirements. Under FDA rules, companies that launch ...

  • Biosimilars revenue to lift AAP - Tue, Sep 15, 2015 12:01 PM AEST

    The US has now seen the first launch in a new category called "biosimilars", near-copies of powerful prescription drugs known as biologics "manufactured" in living cells. Biologics are injected or infused medicines for very serious conditions such as cancer and immune system disorders. Swiss drugmaker Novartis AG recently launched Zarxio, a biosimilar version of Amgen Inc's Neupogen, which boosts white blood cell production to prevent infections in certain cancer and other patients.

  • Solera and Apple are big market movers Associated Press - Tue, Sep 15, 2015 6:56 AM AEST

    Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Solera Holdings Inc., down $4.21 to $53.66 The insurance claims software company ...

  • Raptor shares plummet on failed liver drug study Associated Press - Mon, Sep 14, 2015 10:34 PM AEST

    Shares of Raptor Pharmaceuticals Corp. plunged Monday after the drug developer said its potential liver disease drug failed to meet key treatment goals in a pivotal study and it could end the development ...

  • Primary Health Care founder dies AAP - Mon, Sep 14, 2015 5:32 PM AEST

    The man who transformed a Sydney GP clinic into one of Australia's largest health care providers, Edmund Bateman, has died. Dr Bateman expanded his own general practice in Brookvale into Primary Health Care's first medical centre in 1985, and led the company for almost 30 years as it grew to more than 70 centres. Primary Health Care also has pathology, medical technology and health insurance operations.

  • Bills to regulate medical marijuana head to Gov. Jerry Brown Associated Press - Sat, Sep 12, 2015 4:38 PM AEST
    Bills to regulate medical marijuana head to Gov. Jerry Brown

    With California voters likely to consider legalizing recreational marijuana use next year, state lawmakers approved a package of legislation that would create the first statewide licensing and operating ...

  • Hemp growers upset by proposed marijuana rule changes Associated Press - Fri, Sep 11, 2015 7:37 AM AEST

    An official from the Vermont Department of Public Safety on Wednesday defended proposed new rules on medical marijuana and said fears that they will hurt hemp farmers are unfounded. Lindsay Wells, the ...

  • First 'biosimilar' of a biologic drug reaches US, finally Associated Press - Fri, Sep 11, 2015 6:31 AM AEST

    Years after discounted versions of some of the most expensive drugs ever went on sale in other countries, they're finally coming to the world's biggest medicine market. Last week brought the first U.S. ...

  • Second death reported in nationwide salmonella outbreak Associated Press - Thu, Sep 10, 2015 8:58 AM AEST

    A Texas woman has become the second person to die in a nationwide salmonella outbreak linked to tainted cucumbers sold by a California company, health officials reported Wednesday. The woman, who already ...

  • Major health insurer in NY says computer system was hacked Associated Press - Thu, Sep 10, 2015 5:38 AM AEST

    A health insurer in western New York and affiliates said Wednesday that their computers were targeted last month in a cyberattack that may have provided unauthorized access to more than 10 million personal ...

  • Maine tribe plans to create marijuana cultivation facility Associated Press - Thu, Sep 10, 2015 4:28 AM AEST

    The Passamaquoddy Tribe signed a letter of intent with a medical marijuana management and consulting company to build a cultivation facility in northeastern Maine. Denver-based Monarch America Inc. announced ...

  • New anti-cholesterol drugs too expensive: report AFP - Thu, Sep 10, 2015 2:21 AM AEST
    New anti-cholesterol drugs too expensive: report

    The high price of two new anti-cholesterol drugs limits the benefits patients may see from them, according to a draft report released by a US nonprofit examining drug cost effectiveness. The new drugs, Praluent, from French pharmaceutical giant Sanofi and Regeneron, and Repatha, from California-based Amgen, both target the enzyme PCSK9, which, when inhibited, can lead to reduced LDL-cholesterol. The US Food and Drug Administration approved the medications earlier this year, finding they reduced cholesterol by approximately 55-60% in patients who are already on or who cannot take cholesterol-reducing statin drugs.

  • New anti-cholesterol drugs are too expensive: report AFP - Wed, Sep 9, 2015 11:57 PM AEST
    New anti-cholesterol drugs are too expensive: report

    The high price of two new anti-cholesterol drugs limits the benefits patients may see from them, according to a draft report released Wednesday by a US nonprofit examining drug cost-effectiveness. The US Food and Drug Administration approved the medications earlier this year, finding they reduced cholesterol by approximately 55 to 60% in patients who are already on or who cannot take cholesterol-reducing statin drugs. Wednesday's draft report from the Institute for Clinical and Economic Review (ICER), said those findings "provides moderate certainty that PCSK9 inhibitor therapy improves patient outcomes" and that the two new drugs, which it says are equally effective, may help as many as 3.5 to 15 million Americans.

  • Study finds key GSK-Theravance lung drug didn't extend lives Associated Press - Wed, Sep 9, 2015 8:11 AM AEST

    A closely watched study of GlaxoSmithKline plc's Breo Ellipta respiratory treatment failed to prove that it extends patients' lives, denying the drugmaker a much-needed marketing edge in its most lucrative ...

  • Amsterdam hospital evacuated as pipe break causes flooding Associated Press - Wed, Sep 9, 2015 2:11 AM AEST

    One of Amsterdam's main hospitals was forced to evacuate hundreds of patients Tuesday after a burst water main caused flooding in parts of the building. Wouter Bos, chairman of the board of the Free University ...

  • More precise medical codes aim to track quality of care Associated Press - Tue, Sep 8, 2015 4:49 PM AEST
    More precise medical codes aim to track quality of care

    If things are a bit tense in your doctor's office come Oct. 1, some behind-the-scenes red tape could be to blame. That's the day when the nation's physicians and hospitals must start using a massive new ...

  • Mylan takes takeover bid to Perrigo shareholders AFP - Tue, Sep 8, 2015 4:25 PM AEST
    Mylan takes takeover bid to Perrigo shareholders

    Pharmaceutical company Mylan said Tuesday that it would take its offer to buy Perrigo directly to Perrigo shareholders following refusals by the company's management to engage in merger talks. Mylan, a large generic drugs company, will launch the offer to Perrigo shareholders on Monday and Perrigo shareholders will be eligible to vote until November 13. Perrigo makes over-the-counter medications such as Claritin and Sudafed.

  • Starpharma expects quick drug development AAP - Tue, Sep 8, 2015 12:37 PM AEST

    Biotech Starpharma expects global biopharmaceutical firm AstraZeneca to move quickly to get a cancer drug under joint development into clinical trials and then onto market. Starpharma has signed a licensing deal with AstraZeneca under which AstraZeneca will use Starpharma's drug delivery technology in the development and commercialisation of new cancer drug, followed by other compounds.

  • New medical coding system aims to help track quality of care Associated Press - Tue, Sep 8, 2015 1:31 AM AEST
    New medical coding system aims to help track quality of care

    If things are a bit tense in your doctor's office come Oct. 1, some behind-the-scenes red tape could be to blame. That's the day when the nation's physicians and hospitals must start using a massive new ...

  • Starpharma's shares head for the stars AAP - Mon, Sep 7, 2015 4:38 PM AEST

    Starpharma shares have rocketed after the company announced a drug delivery system deal with global biotech AstraZeneca. Under the agreement, AstraZeneca will develop and commercialise Starpharma's drug delivery system for the treatment for tumours. Starpharma will receive an initial payment of $US2 million ($A2.89 million) with further payments of up to $US124 million.

  • Democrat drops Covered California waiver for immigrants Associated Press - Sat, Sep 5, 2015 7:14 AM AEST
    Democrat drops Covered California waiver for immigrants

    A Democratic state lawmaker on Friday dropped his effort to allow people who are in the country illegally to buy private insurance through the state's health insurance marketplace. Sen. Ricardo Lara, D-Bell ...

  • BYU health plan doesn't meet US contraception, cost rules Associated Press - Fri, Sep 4, 2015 8:33 AM AEST

    Some students at Brigham Young University could face hundreds of dollars in fines if they stay on the school's student health plan, which doesn't comply with federal law in part because it doesn't cover ...

  • Health care costs in Massachusetts surged 4.8 percent in '14 Associated Press - Thu, Sep 3, 2015 4:21 AM AEST

    The cost of health care soared nearly 5 percent in Massachusetts last year despite efforts to hold down expenditures, according to a state report released Wednesday. The Center for Health Information and ...

  • FDA issues warning letters to powdered caffeine distributors Associated Press - Wed, Sep 2, 2015 9:17 AM AEST

    The Food and Drug Administration has issued warning letters to five distributors of pure powdered caffeine, saying the products put consumers at risk. The letters, which are dated Aug. 27, follow the overdose ...